Filter
99
Filtered Results: 99
Text search:
heterologous
Featured
Recommendations
9
New Publications
14
Language
Document type
Guidelines
39
No document type
32
Studies & Reports
12
Manuals
5
Fact sheets
5
Strategic & Response Plan
4
Situation Updates
1
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
Africa
3
Latin America and the Carribbean
3
South Africa
3
Nigeria
2
Mozambique
2
Paraguay
2
Bolivia
2
Russia
2
Chile
1
Philippines
1
Global
1
Asia
1
Tanzania
1
Germany
1
East and Southern Africa
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Guidelines
23
COVID-19
22
Rabies
4
Policies
3
Non-communicable Diseases
3
Virology
2
Malaria
2
Paediatrics
1
Clinical Training
1
Hematology
1
Vaccine-preventable Diseases
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Studies & Reports
1
NTDs & Others
1
Dengue
1
Parasitology
1
Disease Prevention & Control
1
Toolboxes
Country specific documents
13
Inactivated COVID-19 Vaccines
10
Booster Doses
9
Immunization Guidelines
8
Biontech/Pfizer Comirnaty
7
Vaxzevria (Astra Zeneca)
6
Moderna
4
Access & Strategy
3
Research & Access
3
Fair Allocation & Ethical Aspects
2
Johnson & Johnson
2
Covaxin
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Zika
2
Laboratory & Diagnostics
2
Assessment & Studies
1
Vaccines & Immunization
1
Yellow Fever
1
Pediatrics
1
Dengue
1
HIV
1
TB
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Children/Adolescents Mental Disorders
1
Vaccination
1
Children
1
Clinical Guidelines
1
COVID-19
1
For Parents & Children
1
For Older People
1
Communication Material
1
Dashboards & Resource Platforms
1
SARS-CoV-2 Variants
1
Vector-based Vacines General
1
Sputnik V
1
Chile
1
Traditional & Herbal Medicines
1
Zoonoses
1
MPOX - Monkeypox
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
General Information & Methodology
1
Prevention & Strategies
1
Neurological Disorders
1
Food & Nutrition
1
Neurological disorders, Others
1
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Guidelines for Management and Treatment of Dyslipidemia in Indonesia
This algorithm is addressed to laboratories
with established capacity(molecular, antigenic and/orserological) to detect dengue (DENV), Zika (ZIKV), and chikungunya(CHIKV) as part of the differential diagnosis for arborviruses. A BSL2 containment level is required to handle suspected samples.
Este algoritmo está dirigido a aquellos laboratorios que cuentan con capacidad instalada para la detección (molecular, antigénica y/o serológica) de dengue (DENV), Zika (ZIKV) y chikungunya(CHIKV),y como parte del diagnóstico diferencial para Arbovirus. Para la manipulación de muestras sosp...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
7 August 2021
A Organização Mundial da Saúde (OMS), com apoio do Grupo Consultivo Estratégico de Especialistas em Imunização (Strategic Advisory Group of Experts on Immunization – SAGE) e do respectivo Grupo de Trabalho para Vacinas contra a COVID-19, está analisando novas evidências sobre o uso de vaci...
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Additional dose of the primary vaccination against COVID-19: Technical Guidelines
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
Campaña Nacional de Vacunación contra la COVID-19
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access to this transforma...
